MAPT and Alzheimer disease: Transthyretin a marker known to correlate with Aβ42 [16] demonstrated a strong relationship with Aβ42 (Fig. 7a (i)) and p-tau (Fig. 7b (i)) in the AD group but no correlation was observed in the LBD group.